215 related articles for article (PubMed ID: 30255612)
1. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.
Spraker-Perlman HL; Barkauskas DA; Krailo MD; Meyers PA; Schwartz CL; Doski J; Gorlick R; Janeway KA; Isakoff MS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27444. PubMed ID: 30255612
[TBL] [Abstract][Full Text] [Related]
2. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.
Janeway KA; Barkauskas DA; Krailo MD; Meyers PA; Schwartz CL; Ebb DH; Seibel NL; Grier HE; Gorlick R; Marina N
Cancer; 2012 Sep; 118(18):4597-605. PubMed ID: 22252521
[TBL] [Abstract][Full Text] [Related]
3. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
4. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
5. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).
Rodriguez-Galindo C; Shah N; McCarville MB; Billups CA; Neel MN; Rao BN; Daw NC
Cancer; 2004 May; 100(9):1928-35. PubMed ID: 15112274
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
7. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD
Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults.
Eleutério SJ; Senerchia AA; Almeida MT; Da Costa CM; Lustosa D; Calheiros LM; Barreto JH; Brunetto AL; Macedo CR; Petrilli AS
Pediatr Blood Cancer; 2015 Jul; 62(7):1209-13. PubMed ID: 25755160
[TBL] [Abstract][Full Text] [Related]
9. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
[TBL] [Abstract][Full Text] [Related]
12. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
13. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
14. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
15. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
16. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
[TBL] [Abstract][Full Text] [Related]
17. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E; Torricelli E; Cascinu S; Pierini M; De Paolis M; Donati D; Cesari M; Longhi A; Abate M; Paioli A; Setola E; Ferrari S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27792. PubMed ID: 31058424
[TBL] [Abstract][Full Text] [Related]
19. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.
Paludo J; Fritchie K; Haddox CL; Rose PS; Arndt CAS; Marks RS; Galanis E; Okuno SH; Robinson SI
Am J Clin Oncol; 2018 Sep; 41(9):832-837. PubMed ID: 28622153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]